Presented data at ESMO 2025 demonstrating promising efficacy with CRB-701 in head and neck squamous cell carcinoma (HNSCC) ...

Ideal Power Inc. (Nasdaq: IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN(R) bidirectional semiconductor power switch, ...

Full Year 2025 Sales Increased to $59.1 Million, Up 2.3%, Compared to $57.8 Million for the Full Year of 2024. Net sales for the year ended December 31, 2025, were $59.1 million, ...

Supplemental Security Income, or SSI, was created in 1972 to help the nation's most vulnerable. Some features of the program have not been updated in decades.

Favorable early safety and initial efficacy data from BEST1 program highlighted at premier gathering of global retinal experts with additional data expected mid-year 2026 - - Reauthorization of FDA's ...

Completed enrollment in Part B of SIGNAL-AA Phase 2a clinical trial and increased trial size to 33 patients based on patient demand; 36-week topline data readout ...

Badger Infrastructure Solutions Ltd. (“Badger”, the “Company”, “we”, “our” or “us”) (TSX:BDGI) reported fourth quarter and 2025 annual results today. All results are presented in U.S. dollars unless ...

Autohome Inc. (NYSE:ATHM) Q4 2025 Earnings Call Transcript March 5, 2026 Autohome Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $0.36. Operator: Ladies and gentlemen, ...

Free speech on university campuses is a perennially hot topic, perhaps most recently reflected in protests about the Israeli-Palestinian conflict at places like Ball State University, Harvard, and ...

This shareholder letter follows the completion of our fourth quarter and fiscal year ended December 31, 2025.